Baseline: 54.4 percent of sexually active females aged 16 to 24 years enrolled in Medicaid and commercial health plans were screened for chlamydial infections, as reported in 2017
Number of females aged 16 to 24 years who were identified as eligible in the denominator and who had at least 1 test for chlamydia during the measurement year.
Number of females aged 16 to 24 years who were identified as sexually active and who had no more than 1 gap in enrollment of up to 45 days during the measurement year in Medicaid and commercial health plans.
Target-setting method details
Linear trend fitted using ordinary least squares and a projection at the 75 percent prediction interval.
Target-setting method justification
Trend data were evaluated for this objective. Using historical data points, a trend line was fitted using ordinary least squares, and the trend was projected into the next decade. This method was used because three or more comparable data points were available, the projected value was within the range of possible values, and a projection at the 75 percent prediction interval was selected because of the influence of external factors.
Comparable HP2020 objective
Modified, which includes core objectives that are continuing from HP2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from the related Healthy People 2020 objectives in that it is a composite of four objectives that tracked sexually active females who were screened for genital Chlamydia during the measurement year: objectives STD-3.1 and STD 3.2, which tracked females aged 16 to 20 years and 21 to 24 years, respectively, who were enrolled in Medicaid plans; and, objectives STD-4.1 and 4.2, which tracked females aged 16 to 20 years and 21 to 24 years, respectively, who were enrolled in commercial health insurance plans. The phrase "during the measurement year" in not included in the Healthy People 2030 objective statement.